Related Experiment Video
Updated: Jun 21, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular disease mortality in Hispanics and non-Hispanic whites
Carolyn J Swenson1, Mary Jo Trepka, Marian J Rewers
1Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Insights
Hispanics, particularly those with diabetes, showed lower cardiovascular disease (CVD) mortality than non-Hispanic Whites. This suggests underlying factors may protect Hispanic populations from CVD death despite risk profiles.
Area of Science:
- Epidemiology
- Cardiovascular Health
- Diabetes Research
Background:
- Hispanic populations often exhibit a worse cardiovascular disease (CVD) risk profile compared to non-Hispanic Whites.
- Previous studies using death certificates indicated lower CVD mortality rates among Hispanics.
Purpose of the Study:
- To investigate the discrepancy in CVD mortality between Hispanic and non-Hispanic White individuals.
- To examine cause-specific mortality using medical records for a more accurate assessment.
Main Methods:
- Analysis of 310 deaths from 1984-1998 within the San Luis Valley Diabetes Study (1,862 participants).
- Medical records were used to classify the cause of death, differentiating between individuals with and without diabetes.
- Hazard ratios were calculated to compare CVD and coronary heart disease mortality between ethnic groups.
Main Results:
- Among individuals with diabetes, Hispanic participants had significantly lower age-adjusted CVD mortality (8.8/1,000 person-years) compared to non-Hispanic Whites (12.9/1,000 person-years).
- The adjusted hazard ratio for CVD death in diabetic Hispanics versus non-Hispanic Whites was 0.44 (95% CI: 0.26, 0.74).
- A statistically significant decreased risk of CVD death was observed specifically in male Hispanics with diabetes.
Conclusions:
- The study confirms a lower CVD mortality in Hispanics, especially those with diabetes, contradicting their risk profiles.
- Factors interacting with diabetes or competing causes of mortality may explain these observed ethnic differences in CVD outcomes.
Abstract:
Despite a worse cardiovascular disease (CVD) risk profile, Hispanics have lower CVD mortality than non-Hispanic Whites in studies based on death certificates. This study examined 310 deaths that occurred between 1984 and 1998 among 1,862 Hispanic and non-Hispanic White participants in the San Luis Valley Diabetes Study, using medical records to classify cause of death. Among persons without diabetes, the age-adjusted all-cause mortality rate was 6.1/1,000 person-years in non-Hispanic Whites and 7.4/1,000 person-years in Hispanics. Among persons with diabetes, it was 24.3/1,000 person-years in non-Hispanic Whites and 21.9/1,000 person-years in Hispanics. Among nondiabetics, the age-adjusted CVD mortality rate was 2.5/1,000 person-years in non-Hispanic Whites and 1.6/1,000 person-years in Hispanics. Among diabetics, it was 12.9/1,000 person-years in non-Hispanic Whites and 8.8/1,000 person-years in Hispanics. Among nondiabetics, the adjusted hazard ratio for CVD death in Hispanics compared with non-Hispanic Whites was 0.65 (95% confidence interval (CI): 0.34, 1.23). The hazard ratio for coronary heart disease death was 0.95 (95% CI: 0.35, 2.59). Among diabetics, the hazard ratio for CVD death, after adjustment for conventional and diabetes risk factors, was 0.44 (95% CI: 0.26, 0.74), and for coronary heart disease death it was 0.43 (95% CI: 0.21, 0.91). A statistically significant decreased risk of CVD death was observed only in male Hispanics with diabetes. Competing mortality or factors that interact with diabetes may explain these differences.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...